(Circulation. 1997;95:1777-1782.)
© 1997 American Heart Association, Inc.
Articles |
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
From the Division of Preventive Medicine (P.M.R., C.H.H.), the Cardiovascular Division (P.M.R.), and the Channing Laboratory (M.J.S.), Department of Medicine, Brigham and Women's Hospital, and the Department of Ambulatory Care and Prevention (C.H.H.), Harvard Medical School, Boston, Mass; the Departments of Nutrition (M.J.S.) and Epidemiology (M.J.S., C.H.H.), Harvard School of Public Health, Boston, Mass; the Laboratory Medicine Division (J.P.M.), Washington University School of Medicine, St Louis, Mo; the Oregon Regional Primate Research Center (M.R.M.), Beaverton; and the Jean Mayer Human Nutrition Research Center at Tufts University (J.S.), Boston, Mass.
Correspondence to Paul M. Ridker, Department of Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02115. E-mail PMRIDKER{at}BICS.BWH.HARVARD.EDU
Background Because patients with rare familial homocystinuria who also carry factor V Leiden have an increased incidence of venous thromboembolism (VTE), we hypothesized an interrelation of moderate hyperhomocyst(e)inemia, factor V Leiden, and risk of VTE in the general population.
Methods and Results In a large prospective cohort, we determined total homocysteine level and factor V Leiden mutation in baseline blood samples from 145 initially healthy men who subsequently developed VTE and among 646 men who remained free of vascular disease during a 10-year follow-up period. Hyperhomocyst(e)inemia was defined as a total homocysteine level above the 95th percentile (17.25 µmol/L). Compared with men with normal total homocysteine levels, those with hyperhomocyst(e)inemia had no increase in risk of any VTE but were at increased risk of idiopathic VTE (relative risk [RR]=3.4, P=.002). Compared with men without Leiden mutation, those with mutation were at increased risk of developing any VTE (RR=2.3, P=.005) as well as idiopathic VTE (RR=3.6, P=.0002). Compared with men with neither abnormality, those affected by both disorders had a 10-fold increase in risk of any VTE (RR=9.65, P=.009) and a 20-fold increase in risk of idiopathic VTE (RR=21.8, P=.0004).
Conclusions Apparently healthy men with coexistent hyperhomocyst(e)inemia and Leiden mutation are at substantially increased risk of developing future VTEs, particularly those events considered idiopathic. In these data, the risk of VTE among doubly affected individuals was far greater than the sum of the individual risks associated with either abnormality alone.
Key Words: factor V Leiden • thrombosis, venous • homocysteine • embolism, pulmonary
This article has been cited by other articles:
 |
|
 |
|
  V. Ducros, C. Barro, J. Yver, G. Pernod, B. Polack, P. Carpentier, M.-D. Desruet, and J.-L. Bosson Should Plasma Homocysteine Be Used as a Biomarker of Venous Thromboembolism? A Case--Control Study Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 517 - 522. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Franchini and P. M. Mannucci Interactions between genotype and phenotype in bleeding and thrombosis Haematologica, May 1, 2008; 93(5): 649 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Ray, C. Kearon, Q. Yi, P. Sheridan, E. Lonn, and for the Heart Outcomes Prevention Evaluation 2 (HO Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism: A Randomized Trial Ann Intern Med, June 5, 2007; 146(11): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Bagaria, N Modi, A Panghate, and S Vaidya Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study Postgrad. Med. J., February 1, 2006; 82(964): 136 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Connor Factor V Leiden and Its Effect on Children With Cardiac Pathology Journal of Pediatric Oncology Nursing, May 1, 2005; 22(3): 176 - 181. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Saxena, M. Ranalli, N. Khan, C. Blanchong, and S. B. Kahwash Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis Clinical Pediatrics, March 1, 2005; 44(2): 175 - 180. [PDF]
|
|
|
|
|
|
P. T. Murphy Factor V Leiden and Venous Thromboembolism Ann Intern Med, September 21, 2004; 141(6): 483 - 484. [Full Text] [PDF]
|
|
|
|
 |
|
 X.-b. Zhong, R. Reynolds, J. R. Kidd, K. K. Kidd, R. Jenison, R. A. Marlar, and D. C. Ward Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips PNAS, September 30, 2003; 100(20): 11559 - 11564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R Deitcher and M. P. Gomes Hypercoagulable state testing and malignancy screening following venous thromboembolic events Vascular Medicine, February 1, 2003; 8(1): 33 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Meleady, P. M Ueland, H. Blom, A. S Whitehead, H. Refsum, L. E Daly, S. E. Vollset, C. Donohue, B. Giesendorf, I. M Graham, et al. Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project Am. J. Clinical Nutrition, January 1, 2003; 77(1): 63 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. V Joffe and S. Z Goldhaber Laboratory thrombophilias and venous thromboembolism Vascular Medicine, May 1, 2002; 7(2): 93 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Simioni, D. Tormene, P. Prandoni, P. Zerbinati, S. Gavasso, P. Cefalo, and A. Girolami Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study Blood, March 15, 2002; 99(6): 1938 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lee and K. Prasad Hyperhomocysteinemia and Venous Thrombosis International Journal of Lower Extremity Wounds, March 1, 2002; 1(1): 4 - 12. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Cattaneo, R. Lombardi, A. Lecchi, P. Bucciarelli, and P. M. Mannucci Low Plasma Levels of Vitamin B6 Are Independently Associated With a Heightened Risk of Deep-Vein Thrombosis Circulation, November 13, 2001; 104(20): 2442 - 2446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tripodi and P. M. Mannucci Laboratory Investigation of Thrombophilia Clin. Chem., September 1, 2001; 47(9): 1597 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seligsohn and A. Lubetsky Genetic Susceptibility to Venous Thrombosis N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Miles, J. P. Miletich, S. Z. Goldhaber, C. H. Hennekens, and P. M. Ridker G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism J. Am. Coll. Cardiol., January 1, 2001; 37(1): 215 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T C F Sykes, C Fegan, and D Mosquera Thrombophilia, polymorphisms, and vascular disease Mol. Pathol., December 1, 2000; 53(6): 300 - 306. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Stubbs, M. K. Al-Obaidi, R. M. Conroy, MusB, P. O. Collinson, MRCPath, I. M. Graham, FRCPI, and M. I. M. Noble Effect of Plasma Homocysteine Concentration on Early and Late Events in Patients With Acute Coronary Syndromes Circulation, August 8, 2000; 102(6): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ueland, H. Refsum, S. A. Beresford, and S. E. Vollset The controversy over homocysteine and cardiovascular risk Am. J. Clinical Nutrition, August 1, 2000; 72(2): 324 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Klee Cobalamin and Folate Evaluation: Measurement of Methylmalonic Acid and Homocysteine vs Vitamin B12 and Folate Clin. Chem., August 1, 2000; 46(8): 1277 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Khajuria and D. S. Houston Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis Blood, August 1, 2000; 96(3): 966 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men Circulation, April 18, 2000; 101(15): 1767 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Langman, J. G. Ray, J. Evrovski, E. Yeo, and D. E.C. Cole Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism: More Evidence From a Case-Control Study Arch Intern Med, April 10, 2000; 160(7): 961 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Foody, J. A. Milberg, K. Robinson, G. L. Pearce, D. W. Jacobsen, and D. L. Sprecher Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 493 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lanthier, L. Carmant, M. David, A. Larbrisseau, and G. de Veber Stroke in children: The coexistence of multiple risk factors predicts poor outcome Neurology, January 25, 2000; 54(2): 371 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.H. van Boven, J.P. Vandenbroucke, E. Briet, and F.R. Rosendaal Gene-Gene and Gene-Environment Interactions Determine Risk of Thrombosis in Families With Inherited Antithrombin Deficiency Blood, October 15, 1999; 94(8): 2590 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. De Stefano, I. Martinelli, P. M. Mannucci, K. Paciaroni, P. Chiusolo, I. Casorelli, E. Rossi, and G. Leone The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation N. Engl. J. Med., September 9, 1999; 341(11): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. P. Rohde, C. H. Hennekens, and P. M. Ridker Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1595 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. P. Rohde, L. H. Arroyo, N. Rifai, M. A. Creager, P. Libby, P. M. Ridker, and R. T. Lee Plasma Concentrations of Interleukin-6 and Abdominal Aortic Diameter Among Subjects Without Aortic Dilatation Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1695 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gemmati, M. Previati, M. L. Serino, S. Moratelli, S. Guerra, S. Capitani, E. Forini, G. Ballerini, and G. L. Scapoli Low Folate Levels and Thermolabile Methylenetetrahydrofolate Reductase as Primary Determinant of Mild Hyperhomocystinemia in Normal and Thromboembolic Subjects Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1761 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Jay and S. R. Kahn Cigarette Smoking: Risk Factor for Venous Thromboembolic Disease? Arch Intern Med, May 24, 1999; 159(10): 1144 - 1144. [Full Text] [PDF]
|
|
|
|
 |
|
 D. SHEMIN, K. L. LAPANE, L. BAUSSERMAN, E. KANAAN, S. KAHN, L. DWORKIN, and A. G. BOSTOM Plasma Total Homocysteine and Hemodialysis Access Thrombosis: AProspective Study J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1095 - 1099. [Abstract] [Full Text]
|
|
|
|
|
|
O. Salomon, D. M. Steinberg, A. Zivelin, S. Gitel, R. Dardik, N. Rosenberg, S. Berliner, A. Inbal, A. Many, A. Lubetsky, et al. Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism : Prevalence and Risk Assessment Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Kahn The Clinical Diagnosis of Deep Venous Thrombosis: Integrating Incidence, Risk Factors, and Symptoms and Signs Arch Intern Med, November 23, 1998; 158(21): 2315 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. MURIN, G. P. MARELICH, A. C. ARROLIGA, and R. A. MATTHAY Hereditary Thrombophilia and Venous Thromboembolism Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1369 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Rohde, R. T. Lee, J. Rivero, M. Jamacochian, L. H. Arroyo, W. Briggs, N. Rifai, P. Libby, M. A. Creager, and P. M. Ridker Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Ray Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic Disease Arch Intern Med, October 26, 1998; 158(19): 2101 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Laffan Genetics and pulmonary medicine bullet 4: Pulmonary embolism Thorax, August 1, 1998; 53(8): 698 - 702. [Full Text]
|
|
|
|
|
|
S. Z. Goldhaber Pulmonary Embolism N. Engl. J. Med., July 9, 1998; 339(2): 93 - 104. [Full Text] [PDF]
|
|
|
|
|
|
M. Walter, H. Reinecke, G. Breithardt, G. Assmann, J. Heinrich, and P. M. Ridker Factor V Leiden and Thromboembolism • Response Circulation, April 14, 1998; 97(14): 1426 - 1427. [Full Text]
|
|
|
|
|
|
G. N. Welch and J. Loscalzo Homocysteine and Atherothrombosis N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050. [Full Text] [PDF]
|
|
|
|
|
|
L. A.J. Kluijtmans, G. H.J. Boers, B. Verbruggen, F. J.M. Trijbels, I. R.O. Novakova, and H. J. Blom Homozygous Cystathionine beta -Synthase Deficiency, Combined With Factor V Leiden or Thermolabile Methylenetetrahydrofolate Reductase in the Risk of Venous Thrombosis Blood, March 15, 1998; 91(6): 2015 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z Goldhaber Clinical overview of venous thromboembolism Vascular Medicine, February 1, 1998; 3(1): 35 - 40. [Abstract] [PDF]
|
|
|
|
|
|
P. M Ridker and PREVENT Investigators Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial Vascular Medicine, February 1, 1998; 3(1): 67 - 73. [Abstract] [PDF]
|
|
|
|
|
|
A. Ulvik, J. Ren, H. Refsum, and P. M. Ueland Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis Clin. Chem., February 1, 1998; 44(2): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cattaneo, M. L. Monzani, I. Martinelli, C. R. Falcon, P. M. Mannucci, and P. M. Ridker Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism • Response Circulation, January 27, 1998; 97(3): 295 - 296. [Full Text]
|
|
|
|
 |
|
 P. Robbins, M. Forrest, and D. Royston Hypercoagulable States Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 295 - 318. [Abstract] [PDF]
|
|
|
|
 |
|
 Factor V Leiden Risk Not Limited to Young Patients Journal Watch Cardiology, April 28, 1997; 1997(428): 13 - 13. [Full Text]
|
|
|
|
 |
|
 P. M. Ridker, J. P. Miletich, C. H. Hennekens, and J. E. Buring Ethnic Distribution of Factor V Leiden in 4047 Men and Women: Implications for Venous Thromboembolism Screening JAMA, April 23, 1997; 277(16): 1305 - 1307. [Abstract] [PDF]
|
|
|
|
|
|
M. D. Phillips Interrelated Risk Factors for Venous Thromboembolism Circulation, April 1, 1997; 95(7): 1749 - 1751. [Full Text]
|
|
|
|
 |
|
 A. Undas, E. B. Williams, S. Butenas, T. Orfeo, and K. G. Mann Homocysteine Inhibits Inactivation of Factor Va by Activated Protein C J. Biol. Chem., February 2, 2001; 276(6): 4389 - 4397. [Abstract] [Full Text] [PDF]
|
|